SEC Form 3 · accession 0000899243-19-001991
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc D Kozin
Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,000 | I | By Marc D. Kozin Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney